W.F. Wieland

500 total citations
22 papers, 355 citations indexed

About

W.F. Wieland is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, W.F. Wieland has authored 22 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 6 papers in Urology. Recurrent topics in W.F. Wieland's work include Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). W.F. Wieland is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). W.F. Wieland collaborates with scholars based in Germany, Russia and United States. W.F. Wieland's co-authors include Ruth Knuechel, J. Keul, R. P. Kaminski, H.-H. Dickhuth, M. Lehmann, José I. Aramendi, Wolfgang Roessler, Michael Straub, H.J. Kiel and Bernhard Walter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Urology.

In The Last Decade

W.F. Wieland

19 papers receiving 329 citations

Peers

W.F. Wieland
Lina Wong United States
Julia M. Kröpfl Switzerland
Yang Lv China
Wendy Mathews United States
Naoko Onizuka United States
Xu Tang China
W.F. Wieland
Citations per year, relative to W.F. Wieland W.F. Wieland (= 1×) peers Takeya Suzuki

Countries citing papers authored by W.F. Wieland

Since Specialization
Citations

This map shows the geographic impact of W.F. Wieland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.F. Wieland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.F. Wieland more than expected).

Fields of papers citing papers by W.F. Wieland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.F. Wieland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.F. Wieland. The network helps show where W.F. Wieland may publish in the future.

Co-authorship network of co-authors of W.F. Wieland

This figure shows the co-authorship network connecting the top 25 collaborators of W.F. Wieland. A scholar is included among the top collaborators of W.F. Wieland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.F. Wieland. W.F. Wieland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Измайлов, А. А., et al.. (2019). Early Results of Male Stress Incontinence Treatment Using Stromal-Vascular Fraction of Autologous Fat Tissue. SHILAP Revista de lepidopterología. 8(3). 171–175.
2.
Vogelhuber, Martin, Susan Feyerabend, Arnulf Stenzl, et al.. (2014). Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. Cancer Microenvironment. 8(1). 33–41. 12 indexed citations
3.
Bründl, Johannes, et al.. (2013). 944 Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent cancer foci. European Urology Supplements. 12(1). e944–e944. 1 indexed citations
4.
Walter, Bernhard, Martin Vogelhuber, Jochen Grassinger, et al.. (2011). Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology. 29(2). 799–805. 25 indexed citations
5.
Otto, Wolfgang, Fabian Eder, Ferdinand Hofstädter, et al.. (2011). 538 WATERJET AIDED TRANSURETHRAL DISSECTION OF UROTHELIAL CARCINOMA: A PROSPECTIVE CLINICAL STUDY. European Urology Supplements. 10(2). 179–179. 4 indexed citations
6.
Walter, Bernhard, Sebastian Rogenhofer, Martin Vogelhuber, et al.. (2010). Modular therapy approach in metastatic castration-refractory prostate cancer. World Journal of Urology. 28(6). 745–750. 12 indexed citations
7.
Ganzer, Roman, Sebastian Rogenhofer, Bernhard Walter, et al.. (2008). FACTORS PREDICTING THE FORMATION OF BLADDER OUTLET OBSTRUCTION AFTER HIGH-INTENSITY FOCUSSED ULTRASOUND (HIFU) TREATMENT OF LOCALISED PROSTATE CANCER. European Urology Supplements. 7(3). 119–119. 15 indexed citations
8.
Reichle, Albrecht, Bernhard Walter, Anna Berand, et al.. (2007). Induction of complete remission in metastatic hormone-refractory prostate cancer: A combined anti-inflammatory therapy approach. Journal of Clinical Oncology. 25(18_suppl). 15636–15636. 1 indexed citations
9.
Kees, Frieder, et al.. (2006). Serum and Prostatic Tissue Concentrations of Moxifloxacin in Patients Undergoing Transurethral Resection of the Prostate. Journal of Chemotherapy. 18(5). 485–489. 15 indexed citations
11.
Stoehr, Robert, Marilise Escobar Bürger, Stefan Denzinger, et al.. (2004). Deletions of Chromosomes 9 and 8p in Histologically Normal Urothelium of Patients with Bladder Cancer. European Urology. 47(1). 58–63. 52 indexed citations
12.
Bürger, M., et al.. (2003). Histopathological, clinical and molecular characterization of carcinomas of the upper urinary tract with mutator phenotype. European Urology Supplements. 2(6). 9–9. 1 indexed citations
13.
Wimmershoff, M.B., Uwe Pichlmeier, Sigrid Karrer, et al.. (2000). No Generalized Skin Phototoxicity after Intravesical Application of 5-Aminolevulinic Acid for Fluorescence Diagnosis ofSuperficial Bladder Cancer. Urologia Internationalis. 64(3). 126–128. 8 indexed citations
15.
Brockhoff, Gero, et al.. (1998). Evaluation of flow-cytometric three-parameter analysis for EGFR quantification and DNA assessment in human bladder carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 432(1). 77–84. 7 indexed citations
16.
Wieland, W.F., et al.. (1993). [Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells].. PubMed. 77. 129–32. 2 indexed citations
17.
Lehmann, M., H.-H. Dickhuth, R. P. Kaminski, et al.. (1991). Training - Overtraining. A Prospective, Experimental Study with Experienced Middle- and Long-Distance Runners*. International Journal of Sports Medicine. 12(5). 444–452. 117 indexed citations
18.
Staehler, G., Åsa Leonhardt, Albert Knapp, & W.F. Wieland. (1985). Urologische Komplikationen nach Strahlentherapie von Karzinomen des Corpus uteri. Geburtshilfe und Frauenheilkunde. 45(9). 630–633.
19.
Staehler, G., N. Schmeller, & W.F. Wieland. (1984). Harnleiterreimplantation mit Psoaszipfelblase. Urologia Internationalis. 39(3). 143–146. 8 indexed citations
20.
Wieland, W.F., et al.. (1977). The lymphogram in abdominal tuberculosis. Clinical Radiology. 28(6). 653–658. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026